Benchmarks
Tetrazolium salts are widely used to investigate cytotoxicity and cell proliferation and viability. The first assay of this type was described by Mosmann et al. in 1983 (1) . These authors used 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) for their experiments. MTT is a water-soluble yellow dye that is converted into a water-insoluble dark blue formazan by reductive cleavage of the tetrazolium ring. The necessary step of discarding the medium and the solubilization of the formazan prior to its quantification can be troublesome and lead to errors, as reviewed in Marshall et al. (2) .
For this reason, other tetrazolium salts have been described to save time and eliminate potential errors. These are 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), sodium 4-(3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolium)-1,3-benzene disulfonate (WST-1), and sodium 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) (3, 4) . These reagents require an electron coupling reagent for optimal formazan yield. For this, phenazine methosulfate (PMS) is normally used (5) .
Slater et al. (6) demonstrated that the mitochondrial succinate dehydrogenase is involved in the cellular reduction of tetrazolium salts, but as reviewed in Marshall et al. (2) , other cellular components can contribute to the formation of the formazan. The MTT assay also failed to show growth inhibition by genistein because of changes in mitochondrial reductase activity (7) and interferons, due to changes in pH of conditioned medium (8) .
It is not only cells that are able to reduce the tetrazolium salt, but also constituents of media like antioxidants and vitamins have been described to interfere (9) (10) (11) .
Huang et al. (12) showed that serum albumin leads to a decreased signal in the MTS assay in a cell-free system containing ascorbic acid as reducing agent. However, when we used the XTT assay to investigate the effect of albumin conjugates-which we develop as targeted drugs (13)-on the viability of cells, we saw an increase in the signal in the cell-free controls.
We investigated this effect further and demonstrate here a reducing effect of serum albumin in the XTT and the MTT assay, while showing the reasons for it.
XTT, PMS, MTT [≥97.5% thin layer chromotography (TLC)], and human serum albumin (HSA; minimum 96%) were purchased from Sigma-Aldrich (Steinheim, Germany Different serum albumin preparations at increasing concentrations in DPBS were tested in 96-well plates in the XTT assay. Cysteine and GSH dissolved in DPBS at equimolar concentrations to the albumin used were tested in parallel. The total volume of the solutions was 150 μL to which 50 μL XTT (1 mg/mL in DPBS) and 1 μL PMS (0.383 mg/mL in DPBS) were added. Plates were shaken and incubated at 37°C for 4 h. After the incubation, absorbance at 480 nm was read using a microplate reader (μQuant™; Bio-Tek Instruments, Winooski, VT, USA); 680 nm was used as reference wavelength. The same concentrations of HSA in DPBS were used for the MTT assay. The volume of the samples was 100 μL. Ten microliters of MTT solution (10 mg/mL in DPBS) were added to each well and incubated for 4 h at 37°C. Each hour, the plate was shaken. After the incubation period, 100 μL isopropanol were added per well, and absorbance was read at 540 nm using the same plate reader as for the XTT assay; 690 nm was used as reference wavelength. For Pronase treatment, a 10% solution of HSA in DPBS was digested with 10 mg/mL Pronase at 40°C overnight. The undigested protein was separated from peptides and amino acids by Vivaspin concentrators with a cutoff of 5000 Da. These were centrifuged at 15,000× g for 30 min. One hundred fifty Benchmarks microliters of the filtrate were used for the XTT assay, which was performed as previously described. To check the role of sulfhydryl (SH) groups in the observed reductive activity, these were inactivated by treating with NEM. NEM was prepared as a 50-mg/mL (400 mM) stock solution in ethanol and was diluted to 13 mM in a 10% solution of HSA in DPBS or an equimolar concentration of GSH or cysteine (1.5 mM). As a control, the same amount of ethanol was used. For NEM to react with cysteine residues, the samples were incubated at 37°C for 1 h. Afterward, 50 μL XTT reagent were added, and the XTT assay was performed. A control with DPBS, NEM, and XTT was included.
Tetrazolium salts like 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) or sodium 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) that
Statistical analyses were based on at least three independent series of experiments with triplets. Unpaired ttests were used for statistical analysis. Data (mean ± sd) were considered to be statistically significant when the twotailed p-value was <0.05. Calculations were performed online at www.physics. csbsju.edu/stats/t-test.html.
When the XTT assay was performed with cell-free incubations containing medium and HSA from Sigma-Aldrich, we observed a concentration-dependent increase of formazan formation. We tried the same with BSA and observed a similar effect ( Figure 1A ). Both albumins led to a considerable increase in the signals, which could easily lead to an overestimation of cell numbers in a cytotoxicity assay.
To examine whether this effect was due to the preparation of HSA, we also tested the preparation from another company, U.S. Biological, with essentially the same results ( Figure 1A) . The protein itself, and not something that is present in a particular preparation, is responsible for the increased signals.
As the MTT assay is preferred often in toxicity studies due to its lower cost, we investigated the effect of HSA from U.S. Biological in this assay and observed a similar effect as in the XTT assay ( Figure 1B) .
To examine if the protein itself has a catalytic activity or if a low molecular weight compound is responsible for this effect, we digested HSA with Pronase followed by ultra-filtration to remove undigested protein. Assessment of the filtrate in the XTT assay showed that the activity was decreased to 25% of the original activity, but never completely lost.
We therefore concluded that the reducing activity in the albumin was not enzymatic, but a low-molecular weight component of albumin. The lower signal remaining after this procedure could be due to an incomplete digestion or to absorption of peptides to the membrane.
As it has already been described that small thiols like dithiothreitol (DTT) can reduce MTT (9) , and free cysteine residues in proteins contribute to the socalled nothing dehydrogenase reaction when nitro blue tetrazolium (NBT) is used in the detection of dehydrogenase activity in histology (14), we decided to investigate if the effect of albumin in the XTT assay is also due to free SH residues. Serum albumin contains one free cysteine residue at position 34, which is protected from oxidation by the surrounding molecule. For HSA and BSA it is reported that there is 0.7 mol SH per mole albumin (15) . To test this possibility, we analyzed equimolar solutions of cysteine and GSH to those of albumin in the XTT assay and observed a concentration-dependent increase in the signal ( Figure 1C ). GSH and HSA were in the same range, with the signal of GSH being slightly higher, but cysteine gave a much higher signal than either HSA or GSH. Apparently cysteine as free amino acid is a much more potent reducing agent than in a small peptide or protein structure.
In the last step, we wanted to prove that the reduction of the tetrazolium salt is indeed due to cysteine in HSA and therefore we blocked cysteine residues in GSH and HSA with NEM; then we performed a XTT assay and compared the results with the effect of NEM on the free cysteine. The signal of cysteine was completely abolished; that of GSH was reduced by 95%, but also the albumin signal was significantly reduced (see Figure 2 for data for GSH and HSA). This correlates with the findings of Van Noorden et al., who could decrease the nothing dehydrogenase activity to the same extent as in our experiments by adding 10 mM NEM (14) . The incomplete inhibition by NEM could be due to poor accessibility of the Cys-34 in the albumin molecule.
We show here that different albumin preparations from two species increased the signals in the XTT assay, and that the MTT assay was affected by HSA in the Benchmarks same way. Our findings do not agree with those of Huang et al. (12) who reported that serum albumin decreased the signals elicited by ascorbic acid, which is known to reduce tetrazolium salts to formazans (10) . Upon addition of albumin, ascorbic acid is bound to albumin (15) and its reductive activity inhibited. This effect is different to the one reported herein, in which albumin alone reduced XTT and MTT to the corresponding formazan and might explain the observation of Zhang and Cox who observed a 20% higher formazan signal when cells were assayed in 10% fetal calf serum (FCS) rather than in 5% FCS (16) .
Based on these findings, we strongly recommend to be careful with data from XTT and MTT assays when estimating cytotoxicity when albumin or other proteins with free SH groups are present, because the artificial increase in the assay signal, which is not due to cellular reductases, could lead to an underestimation of the cytotoxicity of the compounds to be tested. 
